mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0003 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0003 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0003 |